Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
6/10
T&L Biotechnology
We are professional supplier of Recombinant human IL-7 protein,Recombinant Human IL-15 Protein,Recombinant Human IL-21 Protein,Humanized Anti-Human CD3 mAb,Humanized Anti-Human CD16 mAb,Humanized Anti
Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
6/10
Catalog Number: GMP-TL106
Product Name | |
Generic Name | Anti-Human PD-1 mAb |
Product Information | |
Expression Host | CHO cells |
QC Testing Purity | > 90 % as determined by SDS-PAGE |
Purification | Protein A purified from cell culture supernatant |
Endotoxin Level | < 0.1EU per μg of the protein as determined by the LAL method |
Formulation | Supplied as a 0.22μm filtered solution in PBS, PH 7.4. |
Stability & Storage | 24 months at 2℃ to 8℃. Avoid repeated freeze-thaw cycles. |
Background | |
PD-1 is mainly expressed in activated T or B cells and inhibit cell activation, which is a normal autostable mechanism of immune system. Excessive T / B cell activation can cause autoimmune diseases, so PD-1 is necessary in our body. But tumor microenvironment will induce high expression of PD-1 in infiltrating T cells. Tumor cells also express PD-L1 and PD-L2 and inhibit T cell which fail to kill tumor cells. PD-1 antibody can block this pathway, restore the function of T cells and make T cells continue to kill tumor cells. Therefore, anti-human PD-1 monoclonal antibody are applied to exert a "closed" effect on the expanded T cells in vitro, improving the tumor killing effect of immune cells. | |
References | |
1. Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T (Oct 1994). "Structure and chromosomal localization of the human PD-1gene (PDCD1)". Genomics 23 (3): 704–6. doi:10.1006/geno.1994.1562. PMID 7851902. 2. Fife BT, Pauken KE (Jan 2011). "The role of the PD-1 pathway in autoimmunity and peripheral tolerance". Annals of the New York Academy of Sciences 1217: 45–59. doi:10.1111/j.1749- 6632.2010.05919.x. PMID 21276005. 3. Loftus, Peter (16 Nov 2014). "New Bristol-Myers Drug Helped Skin-Cancer Patients in Trial Live Longer". Retrieved 24 Nov 2014.Francisco LM, Sage PT, Sharpe AH (Jul 2010). "The PD-1 pathway in tolerance and autoimmunity". Immunological Reviews 236: 219–42. doi:10.1111/j.1600-065X.2010.00923.x. PMC 2919275. PMID 20636820. Trial dosage: A customer can apply for up to five samples a year (the actual trial dosage is determined by telephone or email communication).
|